JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2198298, encodeId=0022219829833, content=一直是reviewer assign, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Sat Apr 13 18:56:00 CST 2024, time=2024-04-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111364, encodeId=9b01211136454, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑部动作很快的一本杂志，投稿后5天送审。一审50天，两个审稿人意见，态度非常友好也很专业，二审17天，三审2天。22年投稿量大概在1200篇以上，根据发表文章数量推测接收率大概在30%左右。初审送外审概率很高，投了两次都送审了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32ec5494045, createdName=haruka0131, createdTime=Wed Jan 25 00:26:29 CST 2023, time=2023-01-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2098333, encodeId=68d82098333b7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：内分泌领域 经验分享：6.30日投稿，9.24号接受，期间经历一次修改。审稿人意见都不错~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Thu Nov 03 20:36:16 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227237, encodeId=6725122e2376c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e38208621, createdName=ms2000001757641628, createdTime=Sat Jun 18 17:38:12 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093011, encodeId=fe0e1093011b9, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-04-13 1234456789 来自江苏省

一直是reviewer assign

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2198298, encodeId=0022219829833, content=一直是reviewer assign, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Sat Apr 13 18:56:00 CST 2024, time=2024-04-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111364, encodeId=9b01211136454, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑部动作很快的一本杂志，投稿后5天送审。一审50天，两个审稿人意见，态度非常友好也很专业，二审17天，三审2天。22年投稿量大概在1200篇以上，根据发表文章数量推测接收率大概在30%左右。初审送外审概率很高，投了两次都送审了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32ec5494045, createdName=haruka0131, createdTime=Wed Jan 25 00:26:29 CST 2023, time=2023-01-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2098333, encodeId=68d82098333b7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：内分泌领域 经验分享：6.30日投稿，9.24号接受，期间经历一次修改。审稿人意见都不错~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Thu Nov 03 20:36:16 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227237, encodeId=6725122e2376c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e38208621, createdName=ms2000001757641628, createdTime=Sat Jun 18 17:38:12 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093011, encodeId=fe0e1093011b9, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-03-22 嘟嘟啦啦啦来自辽宁省

editor assigned 2周了，啥时候能外审那

7 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198298, encodeId=0022219829833, content=一直是reviewer assign, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Sat Apr 13 18:56:00 CST 2024, time=2024-04-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111364, encodeId=9b01211136454, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑部动作很快的一本杂志，投稿后5天送审。一审50天，两个审稿人意见，态度非常友好也很专业，二审17天，三审2天。22年投稿量大概在1200篇以上，根据发表文章数量推测接收率大概在30%左右。初审送外审概率很高，投了两次都送审了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32ec5494045, createdName=haruka0131, createdTime=Wed Jan 25 00:26:29 CST 2023, time=2023-01-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2098333, encodeId=68d82098333b7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：内分泌领域 经验分享：6.30日投稿，9.24号接受，期间经历一次修改。审稿人意见都不错~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Thu Nov 03 20:36:16 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227237, encodeId=6725122e2376c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e38208621, createdName=ms2000001757641628, createdTime=Sat Jun 18 17:38:12 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093011, encodeId=fe0e1093011b9, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-01-13 ms9000002137545467 来自广东省

审稿速度:12.0 | 投稿命中率:5.0
经验分享：傅

16 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198298, encodeId=0022219829833, content=一直是reviewer assign, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Sat Apr 13 18:56:00 CST 2024, time=2024-04-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111364, encodeId=9b01211136454, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑部动作很快的一本杂志，投稿后5天送审。一审50天，两个审稿人意见，态度非常友好也很专业，二审17天，三审2天。22年投稿量大概在1200篇以上，根据发表文章数量推测接收率大概在30%左右。初审送外审概率很高，投了两次都送审了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32ec5494045, createdName=haruka0131, createdTime=Wed Jan 25 00:26:29 CST 2023, time=2023-01-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2098333, encodeId=68d82098333b7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：内分泌领域 经验分享：6.30日投稿，9.24号接受，期间经历一次修改。审稿人意见都不错~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Thu Nov 03 20:36:16 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227237, encodeId=6725122e2376c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e38208621, createdName=ms2000001757641628, createdTime=Sat Jun 18 17:38:12 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093011, encodeId=fe0e1093011b9, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-02-11 x点诱1995 来自上海

审稿速度:3.0 | 投稿命中率:75.0
经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。

46 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198298, encodeId=0022219829833, content=一直是reviewer assign, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Sat Apr 13 18:56:00 CST 2024, time=2024-04-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111364, encodeId=9b01211136454, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑部动作很快的一本杂志，投稿后5天送审。一审50天，两个审稿人意见，态度非常友好也很专业，二审17天，三审2天。22年投稿量大概在1200篇以上，根据发表文章数量推测接收率大概在30%左右。初审送外审概率很高，投了两次都送审了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32ec5494045, createdName=haruka0131, createdTime=Wed Jan 25 00:26:29 CST 2023, time=2023-01-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2098333, encodeId=68d82098333b7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：内分泌领域 经验分享：6.30日投稿，9.24号接受，期间经历一次修改。审稿人意见都不错~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Thu Nov 03 20:36:16 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227237, encodeId=6725122e2376c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e38208621, createdName=ms2000001757641628, createdTime=Sat Jun 18 17:38:12 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093011, encodeId=fe0e1093011b9, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2013-06-22 albertang

审稿速度:3.0 | 投稿命中率:75.0
经验分享：还好, 临床的容易发...

458 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198298, encodeId=0022219829833, content=一直是reviewer assign, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Sat Apr 13 18:56:00 CST 2024, time=2024-04-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111364, encodeId=9b01211136454, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑部动作很快的一本杂志，投稿后5天送审。一审50天，两个审稿人意见，态度非常友好也很专业，二审17天，三审2天。22年投稿量大概在1200篇以上，根据发表文章数量推测接收率大概在30%左右。初审送外审概率很高，投了两次都送审了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32ec5494045, createdName=haruka0131, createdTime=Wed Jan 25 00:26:29 CST 2023, time=2023-01-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2098333, encodeId=68d82098333b7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：内分泌领域 经验分享：6.30日投稿，9.24号接受，期间经历一次修改。审稿人意见都不错~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Thu Nov 03 20:36:16 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227237, encodeId=6725122e2376c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e38208621, createdName=ms2000001757641628, createdTime=Sat Jun 18 17:38:12 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093011, encodeId=fe0e1093011b9, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-02-17 ms5000001996918480 来自江苏省

请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？

50 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198298, encodeId=0022219829833, content=一直是reviewer assign, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Sat Apr 13 18:56:00 CST 2024, time=2024-04-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111364, encodeId=9b01211136454, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑部动作很快的一本杂志，投稿后5天送审。一审50天，两个审稿人意见，态度非常友好也很专业，二审17天，三审2天。22年投稿量大概在1200篇以上，根据发表文章数量推测接收率大概在30%左右。初审送外审概率很高，投了两次都送审了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32ec5494045, createdName=haruka0131, createdTime=Wed Jan 25 00:26:29 CST 2023, time=2023-01-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2098333, encodeId=68d82098333b7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：内分泌领域 经验分享：6.30日投稿，9.24号接受，期间经历一次修改。审稿人意见都不错~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Thu Nov 03 20:36:16 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227237, encodeId=6725122e2376c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e38208621, createdName=ms2000001757641628, createdTime=Sat Jun 18 17:38:12 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093011, encodeId=fe0e1093011b9, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-01-25 haruka0131 来自福建省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：编辑部动作很快的一本杂志，投稿后5天送审。一审50天，两个审稿人意见，态度非常友好也很专业，二审17天，三审2天。22年投稿量大概在1200篇以上，根据发表文章数量推测接收率大概在30%左右。初审送外审概率很高，投了两次都送审了。

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2198298, encodeId=0022219829833, content=一直是reviewer assign, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Sat Apr 13 18:56:00 CST 2024, time=2024-04-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111364, encodeId=9b01211136454, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑部动作很快的一本杂志，投稿后5天送审。一审50天，两个审稿人意见，态度非常友好也很专业，二审17天，三审2天。22年投稿量大概在1200篇以上，根据发表文章数量推测接收率大概在30%左右。初审送外审概率很高，投了两次都送审了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32ec5494045, createdName=haruka0131, createdTime=Wed Jan 25 00:26:29 CST 2023, time=2023-01-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2098333, encodeId=68d82098333b7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：内分泌领域 经验分享：6.30日投稿，9.24号接受，期间经历一次修改。审稿人意见都不错~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Thu Nov 03 20:36:16 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227237, encodeId=6725122e2376c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e38208621, createdName=ms2000001757641628, createdTime=Sat Jun 18 17:38:12 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093011, encodeId=fe0e1093011b9, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-11-03 x点诱1995

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：内分泌领域
经验分享：6.30日投稿，9.24号接受，期间经历一次修改。审稿人意见都不错~

56 0

[GetPortalCommentsPageByObjectIdResponse(id=2198298, encodeId=0022219829833, content=一直是reviewer assign, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Sat Apr 13 18:56:00 CST 2024, time=2024-04-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111364, encodeId=9b01211136454, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑部动作很快的一本杂志，投稿后5天送审。一审50天，两个审稿人意见，态度非常友好也很专业，二审17天，三审2天。22年投稿量大概在1200篇以上，根据发表文章数量推测接收率大概在30%左右。初审送外审概率很高，投了两次都送审了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32ec5494045, createdName=haruka0131, createdTime=Wed Jan 25 00:26:29 CST 2023, time=2023-01-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2098333, encodeId=68d82098333b7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：内分泌领域 经验分享：6.30日投稿，9.24号接受，期间经历一次修改。审稿人意见都不错~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Thu Nov 03 20:36:16 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227237, encodeId=6725122e2376c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e38208621, createdName=ms2000001757641628, createdTime=Sat Jun 18 17:38:12 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093011, encodeId=fe0e1093011b9, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-06-18 ms2000001757641628

无

61 0

[GetPortalCommentsPageByObjectIdResponse(id=2198298, encodeId=0022219829833, content=一直是reviewer assign, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Sat Apr 13 18:56:00 CST 2024, time=2024-04-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111364, encodeId=9b01211136454, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑部动作很快的一本杂志，投稿后5天送审。一审50天，两个审稿人意见，态度非常友好也很专业，二审17天，三审2天。22年投稿量大概在1200篇以上，根据发表文章数量推测接收率大概在30%左右。初审送外审概率很高，投了两次都送审了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32ec5494045, createdName=haruka0131, createdTime=Wed Jan 25 00:26:29 CST 2023, time=2023-01-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2098333, encodeId=68d82098333b7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：内分泌领域 经验分享：6.30日投稿，9.24号接受，期间经历一次修改。审稿人意见都不错~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Thu Nov 03 20:36:16 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227237, encodeId=6725122e2376c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e38208621, createdName=ms2000001757641628, createdTime=Sat Jun 18 17:38:12 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093011, encodeId=fe0e1093011b9, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 学医的彭于晏

水刊真的不值得选择吗？什么情况下可选择水刊投稿？

72 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务